Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
2.290
+0.050 (2.23%)
At close: Jul 28, 2025, 4:00 PM
2.200
-0.090 (-3.93%)
Pre-market: Jul 29, 2025, 4:22 AM EDT

Ensysce Biosciences Revenue

Ensysce Biosciences had revenue of $1.32M in the quarter ending March 31, 2025, with 331.69% growth. This brings the company's revenue in the last twelve months to $6.22M, up 256.35% year-over-year. In the year 2024, Ensysce Biosciences had annual revenue of $5.21M with 133.58% growth.

Revenue (ttm)
$6.22M
Revenue Growth
+256.35%
P/S Ratio
0.35
Revenue / Employee
$778,010
Employees
8
Market Cap
5.43M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20245.21M2.98M133.58%
Dec 31, 20232.23M-292.86K-11.61%
Dec 31, 20222.52M-1.01M-28.54%
Dec 31, 20213.53M-400.01K-10.18%
Dec 31, 20203.93M2.17M122.86%
Dec 31, 2019 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.